Advanced search
Publication Cover
Seminars in Ophthalmology Volume 39, 2024 - Issue 5
Submit an article Journal homepage
39
Views
0
CrossRef citations to date
0
Altmetric
Research Article

New Multi-Parameters Combination of Technetium-99m-Diethylene-Triamine-Pentaacetate Orbital Single-Photon Emission Computed Tomography/Computed Tomography for the Evaluation of Graves’ Orbitopathy Activity

Lixin Suna Department of Nuclear Medicine, Beijing Luhe Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Ruchen Pengb Department of Radiology, Beijing Luhe Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Rongxin Sunc Department of Endocrinology and Metabolism, Beijing Luhe Hospital, Capital Medical University, Beijing, ChinaView further author information
Pages 387-393 | Received 23 Dec 2023, Accepted 22 Feb 2024, Published online: 27 Feb 2024

REFERENCES

  • Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362(8):726–38. doi:10.1056/NEJMra0905750.
  • Perros P, Hegedus L, Bartalena L, Marcocci C, Kahaly GJ, Baldeschi L, et al. Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement. Orphanet J Rare Dis. 2017;12(1):72. doi:10.1186/s13023-017-0625-1.
  • Bartley GB. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc. 1994;92:477–588.
  • Laurberg P, Berman DC, Bulow Pedersen I, Andersen S, Carle A. Incidence and clinical presentation of moderate to severe graves’ orbitopathy in a Danish population before and after iodine fortification of salt. J Clin Endocrinol Metab. 2012;97(7):2325–32. doi:10.1210/jc.2012-1275.
  • Gagliardo C, Radellini S, Morreale Bubella R, Falanga G, Richiusa P, Vadala M, et al. Lacrimal gland herniation in graves ophthalmopathy: a simple and useful MRI biomarker of disease activity. Eur Radiol. 2020;30(4):2138–41. doi:10.1007/s00330-019-06570-5.
  • Eckstein AK, Finkenrath A, Heiligenhaus A, Renzing-Kohler K, Esser J, Kruger C. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand. 2004;82(3p1):291–297. doi:10.1111/j.1395-3907.2004.00268.x.
  • Xu N, Cui Y, Fu D, Sun F. Tear inflammatory cytokines and ocular surface changes in patients with active thyroid eye disease treated with high-dose intravenous glucocorticoids. J Endocrinol Invest. 2020;43(7):901–10. doi:10.1007/s40618-019-01174-8.
  • Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C. The 2021 European group on graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of graves’ orbitopathy. Eur J Endocrinol. 2021;185(4):G43–G67. doi:10.1530/EJE-21-0479.
  • Rui ZY, Yin X, Wang X, Shen J, Zheng W. A retrospective study of clinical features and prognosis of patients with graves’ disease and ophthalmopathy. Nucl Med Commun. 2023;44(2):137–141. doi:10.1097/MNM.0000000000001649.
  • Civrny J, Karhanova M, Hubnerova P, Schovanek J, Herman M. MRI in the assessment of thyroid-associated orbitopathy activity. Clin Radiol. 2022;77(12):925–934. doi:10.1016/j.crad.2022.08.124.
  • Jiang M, Song X, Zhang H, Tao X, Yang G, Wang Y, et al. The combination of T2-mapping value of lacrimal gland and clinical indicators can improve the stage prediction of graves’ ophthalmopathy compared to clinical activity scores. Endocrine. 2022;78(2):321–28. doi:10.1007/s12020-022-03167-9.
  • Galuska L, Leovey A, Szucs-Farkas Z, Garai I, Szabo J, Varga J. SPECT using 99mTc-DTPA for the assessment of disease activity in gravesʼ ophthalmopathy: a comparison with the results from MRI. Nucl Med Commun. 2002;23(12):1211–1216. doi:10.1097/00006231-200212000-00010.
  • Zhao RX, Shi TT, Luo S, Liu YF, Xin Z, Yang JK. The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of graves’ orbitopathy. Endocr Connect. 2022;11(2):e210590. doi:10.1530/EC-21-0590.
  • Szumowski P, Abdelrazek S, Zukowski L, Mojsak M, Sykala M, Siewko K. Efficacy of 99mTc-DTPA SPECT/CT in diagnosing orbitopathy in graves’ disease. BMC Endocr Disord. 2019;19(1):10. doi:10.1186/s12902-019-0340-0.
  • Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, et al. The 2016 European thyroid association/European group on graves’ orbitopathy guidelines for the management of graves’ orbitopathy. Eur Thyroid J. 2016;5 (1) :9–26. doi:10.1159/000443828.
  • Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C. Consensus statement of the European Group on graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158 (3) :273–285. doi:10.1530/EJE-07-0666.
  • Kahaly G, Schrezenmeir J, Krause U, Schweikert B, Meuer S, Muller W. Ciclosporin and prednisone v. prednisone in treatment of graves’ ophthalmopathy: a controlled, randomized and prospective study. Eur J Clin Invest. 1986;16(5):415–422. doi:10.1111/j.1365-2362.1986.tb01016.x.
  • Ujhelyi B, Erdei A, Galuska L, Varga J, Szabados L, Balazs E. Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in graves’ ophthalmopathy. Thyroid. 2009;19(4):375–380. doi:10.1089/thy.2008.0298.
  • Sun R, Zhou HF, Fan XQ. Ocular surface changes in graves’ ophthalmopathy. Int J Ophthalmol. 2021;14(4):616–621. doi:10.18240/ijo.2021.04.20.
  • Liu D, Xu X, Wang S, Jiang C, Li X, Tan J. 99mTc-DTPA SPECT/CT provided guide on triamcinolone therapy in graves’ ophthalmopathy patients. Int Ophthalmol. 2020;40(3):553–61. doi:10.1007/s10792-019-01213-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.